the threat of influenza is formidable
but now so are your vaccine options

Only 2 Influenza Vaccines Have Been Proven to Prevent More Cases of Influenza versus Standard-Dose Vaccine Comparators in older adults1-4

According to a head-to-head randomized controlled efficacy trial among adults 65+ years of age, FLUZONE HIGH-DOSE was proven to provide 24%-51% better protection from influenza versus Fluzone (Influenza Vaccine), a standard-dose influenza vaccine.1,3

Based on data from Fluzone High-Dose, solicited injection site reactions and systemic adverse reactions were slightly more frequent after vaccination with Fluzone High-Dose compared to a standard-dose vaccine.1

A QUADRIVALENT FORMULATION OF FLUZONE HIGH-DOSE

  • Helps to protect against 2 influenza A strains and BOTH INFLUENZA B LINEAGES that co-circulate unpredictably each season1
  • 4X THE AMOUNT OF ANTIGEN of standard-dose quadrivalent inactivated influenza vaccine5
  • 0.7-mL dose for intramuscular injection1
  • Similar safety profile to Fluzone High-Dose trivalent vaccine1

According to a head-to-head randomized controlled trial among adults 50+ years of age, FLUBLOK QUADRIVALENT was proven to provide 30%-43% better protection from influenza versus a standard-dose quadrivalent inactivated influenza vaccine.2,4

In this randomized controlled trial, the most common local and systemic adverse reactions to Flublok Quadrivalent included pain at the injection site, headache, and fatigue.2

AN INFLUENZA VACCINE WITH A UNIQUE COMPOSITION

  • 3X more hemagglutinin antigen versus a standard-dose quadrivalent inactivated influenza vaccine6
  • Similar safety profile compared to a standard-dose inactivated influenza vaccine2
  • Made with RECOMBINANT DNA TECHNOLOGY4:
    • Eliminates the need to grow influenza virus during manufacturing, which ensures hemagglutinin antigen cannot adapt or mutate
    • Avoids changes in hemagglutinin antigen structure that can lead to reduced vaccine effectiveness


Fluzone Quadrivalent for patients 6+ months
  • 4-strain defense that helps protect patients 6+ months7

Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent are vaccines indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and influenza type B viruses contained in the vaccine. Fluzone Quadrivalent is approved for use in persons 6 months of age and older. Flublok Quadrivalent is approved for use in persons 18 years of age and older. Fluzone High-Dose Quadrivalent is approved for use in persons 65 years of age and older.

You are about to leave
Sanofiflu.com

You are being directed to VaccineShoppe.com®.
Would you like to continue?